Pfizer's AI-Driven Breakthroughs in Biologics: Revolutionizing Drug Discovery in 2024
Top pharmaceutical companies like Pfizer, Roche, and AstraZeneca are leveraging AI, M&A, and regulatory reforms to accelerate biologics innovation in 2024 | Developments in drug discovery, personalized medicine, and next-gen manufacturing technologies
